Lisa A Carey, MD
UNC Lineberger Comprehensive Cancer Center · University of North Carolina · University of North Carolina, Chapel Hill
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Lisa A Carey, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:41 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07340541 · Evolutionary Clinical Trial for Novel Biomarker-Driven TherapiesUNC Lineberger Comprehensive Cancer Center · recruiting · Breast Cancer, Metastatic Breast Cancer, Triple Negative Breast Cancer · principal investigator
- Ph3NCT05207709 · Ribociclib vs. Palbociclib in Patients With Advanced Breast Cancer Within the HER2-Enriched Intrinsic SubtypeSOLTI Breast Cancer Research Group · terminated · Metastatic Breast Cancer · principal investigator
- N/ANCT03769415 · Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCAUNC Lineberger Comprehensive Cancer Center · recruiting · Breast Cancer · principal investigator
- N/ANCT03161821 · Circulating Tumor Cells in Solid TumorsUNC Lineberger Comprehensive Cancer Center · completed · Solid Tumor, Adult · principal investigator
- Early Ph1NCT01875666 · Defining the HER2 Positive (+) Breast Cancer Kinome Response to Trastuzumab, Pertuzumab, Combination Trastuzumab +Pertuzumab, or Combination Trastuzumab + LapatinibUNC Lineberger Comprehensive Cancer Center · completed · Breast Neoplasms · principal investigator
- N/ANCT01000883 · Correlation of Molecular Markers With Response to Therapy and Breast Cancer BehaviorUNC Lineberger Comprehensive Cancer Center · recruiting · Breast Cancer · principal investigator
- Ph2NCT00764322 · Studying Blood Samples From Women With Breast Cancer or Ductal Carcinoma In Situ Who Are Receiving TamoxifenUNC Lineberger Comprehensive Cancer Center · completed · Breast Cancer, Menopausal Symptoms · principal investigator
- Ph2NCT00232505 · Cetuximab + / - Carboplatin for Estrogen Receptor-Negative, Progesterone Receptor-Negative Metastatic Breast CancerUNC Lineberger Comprehensive Cancer Center · completed · Breast Cancer · principal investigator
- Ph2NCT00006110 · Multimodality Treatment for Women With Stage II, Stage III, or Stage IV Breast CancerUNC Lineberger Comprehensive Cancer Center · completed · Breast Cancer · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:41 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- SPORE in Breast CancerP50CA058223 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LISA A CAREY, Gaorav P. Gupta, CHARLES M PEROU · fiscal years 2018 to 2026Named on NCT01000883
- Clinical Research ProgramP30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Matthew I Milowsky · fiscal years 2017 to 2026Named on NCT01000883, NCT00764322
- M01RR000046RePORTER returned no project for this number; it is shown as the registry gives it.Named on NCT00232505
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in breast cancer.